Deutsch
TU Dresden

search
11.10.2018

DFG priority programme funds innovative eye research in Dresden

The four research group leaders Dr. Volker Busskamp, Dr. Mike O. Karl, Prof. Dr. Marius Ader und Prof. Dr. Jochen Guck (from left to right) © Friederike Braun

Within the Priority Programme 2127 "Gene and Cell-based Therapies to Counteract Neuroretinal Degeneration" the German Research Foundation (DFG) provides funding of more than one million Euros for three years to four research groups at the Center for Regenerative Therapies Dresden (CRTD) and the Biotechnology Center (BIOTEC), both part of the Center for Molecular and Cellular Bioengineering (CMCB) of the TU Dresden, as well as at the German Center for Neurodegenerative Diseases (DZNE) in Dresden.

The SPP2127 brings together 29 experts in vision research and clinical ophthalmology to develop gene- and cell-based therapies for the treatment of currently incurable blinding diseases in a German-wide network. The funded projects will further strengthen this research direction within the Dresden life science network including pioneering approaches in regenerative therapies utilizing human induced pluripotent stem cells (hiPSC), genome engineering and label-free sorting technologies.

Complete press release